Article
FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism.
Nature communications - 13 Feb 2020
Chen Xin, Ji Boyang, Hao Xinxin, Li Xiaowei, Eisele Frederik, Nyström Thomas, Petranovic Dina
Abstract excerpt
Alzheimer's disease (AD) is defined by progressive neurodegeneration, with oligomerization and aggregation of amyloid-β peptides (Aβ) playing a pivotal role in its pathogenesis. In recent years, the yeast Saccharomyces cerevisiae has been successfully used to clarify the roles of different human proteins involved in neurodegeneration. Here, we report a genome-wide synthetic genetic interaction array to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
